TCR-β and TCR-γ analysis in skin, lymph node, and peripheral blood samples of 23 CTCL patients
| Case . | Disease . | Stage (TNM) . | TCR-β-R . | TCR-γ-R . | ||||
|---|---|---|---|---|---|---|---|---|
| Skin . | LN . | Blood . | Skin . | LN . | Blood . | |||
| 1 | MF | T3N3M0 | + | na | na | + | na | na |
| 2 | MF | T3N0M0 | + | + | na | + | + | na |
| 3 | MF | T3N0M0 | + | na | na | − | na | na |
| 4 | MF | T3N0M0 | + | na | na | + | na | na |
| 5 | MF | T4N0M0 | + | − | − | − | − | − |
| 6 | MF | T4N0M0 | + | + | na | + | + | na |
| 7 | MF | T3N3M0 | + | + | na | + | + | na |
| 8 | MF | T3N3M0 | + | + | − | − | na | na |
| 9 | MF | T3N3M0 | + | + | − | − | − | − |
| 10 | MF | T4N3M0 | + | + | na | + | + | na |
| 11 | MF | T4N3M0 | + | + | na | + | + | na |
| 12 | MF | T4N3M0 | + | + | − | + | + | − |
| 13 | MF | T4N3M0 | + | + | + | + | na | na |
| 14 | MF | T3N3M0 | + | + | + | + | + | − |
| 15 | MF | T4N3M0 | + | na | na | + | na | na |
| 16 | MF | T2N3M0 | + | na | na | + | na | na |
| 17 | MF | T3N3M0 | + | + | + | − | − | − |
| 18 | MF | T2N3M0 | + | + | na | + | + | na |
| 19 | MF | T2N3B1M0 | + | + | na | − | − | na |
| 20 | SS | T4N3B1M0 | + | + | + | + | + | + |
| 21 | SS | T4N3B1M0 | + | + | + | + | + | + |
| 22 | SS | T4N3B1M1 | + | + | + | + | + | + |
| 23 | SS | T4N3B1M1 | + | + | + | + | + | + |
| Case . | Disease . | Stage (TNM) . | TCR-β-R . | TCR-γ-R . | ||||
|---|---|---|---|---|---|---|---|---|
| Skin . | LN . | Blood . | Skin . | LN . | Blood . | |||
| 1 | MF | T3N3M0 | + | na | na | + | na | na |
| 2 | MF | T3N0M0 | + | + | na | + | + | na |
| 3 | MF | T3N0M0 | + | na | na | − | na | na |
| 4 | MF | T3N0M0 | + | na | na | + | na | na |
| 5 | MF | T4N0M0 | + | − | − | − | − | − |
| 6 | MF | T4N0M0 | + | + | na | + | + | na |
| 7 | MF | T3N3M0 | + | + | na | + | + | na |
| 8 | MF | T3N3M0 | + | + | − | − | na | na |
| 9 | MF | T3N3M0 | + | + | − | − | − | − |
| 10 | MF | T4N3M0 | + | + | na | + | + | na |
| 11 | MF | T4N3M0 | + | + | na | + | + | na |
| 12 | MF | T4N3M0 | + | + | − | + | + | − |
| 13 | MF | T4N3M0 | + | + | + | + | na | na |
| 14 | MF | T3N3M0 | + | + | + | + | + | − |
| 15 | MF | T4N3M0 | + | na | na | + | na | na |
| 16 | MF | T2N3M0 | + | na | na | + | na | na |
| 17 | MF | T3N3M0 | + | + | + | − | − | − |
| 18 | MF | T2N3M0 | + | + | na | + | + | na |
| 19 | MF | T2N3B1M0 | + | + | na | − | − | na |
| 20 | SS | T4N3B1M0 | + | + | + | + | + | + |
| 21 | SS | T4N3B1M0 | + | + | + | + | + | + |
| 22 | SS | T4N3B1M1 | + | + | + | + | + | + |
| 23 | SS | T4N3B1M1 | + | + | + | + | + | + |
LN, lymph node; na, not analyzed; +, monoclonal; −, not monoclonal; MF, mycosis fungoides; SS, Sézary syndrome.